Literature DB >> 23851963

α-[11C]-Methyl-L-tryptophan--PET in 191 patients with tuberous sclerosis complex.

Harry T Chugani1, Aimee F Luat, Ajay Kumar, Rajkumar Govindan, Kathy Pawlik, Eishi Asano.   

Abstract

OBJECTIVES: This was an observational study done on a large cohort of patients with tuberous sclerosis complex (TSC) to determine whether i) the presence of α-[(11)C]-methyl-l-tryptophan (AMT) hotspots is related to the duration of seizure intractability, ii) the presence of AMT hotspots is related to specific TSC gene mutations, and iii) there is concordance between areas with an AMT hotspot and seizure lateralization/localization on scalp EEG.
METHODS: One hundred ninety-one patients (mean age: 6.7 years; median: 5 years; range: 3 months to 37 years) with TSC and intractable epilepsy were included. All patients underwent AMT-PET scan. AMT uptake in each tuber and normal-appearing cortex was measured and correlated with clinical, scalp EEG, and, if available, electrocorticographic data.
RESULTS: The longer the duration of seizure intractability, the greater the number of AMT hotspots (r = 0.2; p = 0.03). AMT hotspots were seen in both TSC1 and TSC2. There was excellent agreement in seizure focus lateralization between ictal scalp EEG and AMT-PET (Cohen κ 0.94) in 68 of 95 patients in whom both ictal video-EEG and AMT-PET showed lateralizing findings; in 28 of 68 patients (41%), AMT was more localizing. Furthermore, AMT-PET was localizing in 10 of 17 patients (58%) with nonlateralized ictal EEG.
CONCLUSION: AMT-PET, when used together with video-EEG, provides additional lateralization/localization data, regardless of TSC mutation. The duration of seizure intractability may predict the multiplicity of areas with AMT hotspots.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23851963      PMCID: PMC3775695          DOI: 10.1212/WNL.0b013e3182a08f3f

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  29 in total

Review 1.  α-methyl-L-tryptophan: mechanisms for tracer localization of epileptogenic brain regions.

Authors:  Diane C Chugani
Journal:  Biomark Med       Date:  2011-10       Impact factor: 2.851

2.  Prognostic significance of tuber count and location in tuberous sclerosis complex.

Authors:  Colin Doherty; Suzanne Goh; Tina Young Poussaint; Namik Erdag; Elizabeth A Thiele
Journal:  J Child Neurol       Date:  2005-10       Impact factor: 1.987

3.  Multimodality imaging for improved detection of epileptogenic foci in tuberous sclerosis complex.

Authors:  E Asano; D C Chugani; O Muzik; C Shen; C Juhász; J Janisse; J Ager; A Canady; J R Shah; A K Shah; C Watson; H T Chugani
Journal:  Neurology       Date:  2000-05-23       Impact factor: 9.910

4.  Magnetoencephalography in patients with tuberous sclerosis and localization-related epilepsy.

Authors:  Takanori Kamimura; Jun Tohyama; Makoto Oishi; Noriyuki Akasaka; Osamu Kanazawa; Mutsuo Sasagawa; Mitsuhiro Kato; Kousaku Ohno; Hiroshi Masuda; Shigeki Kameyama; Makoto Uchiyama
Journal:  Epilepsia       Date:  2006-06       Impact factor: 5.864

5.  An interactive technique for three-dimensional image registration: validation for PET, SPECT, MRI and CT brain studies.

Authors:  U Pietrzyk; K Herholz; G Fink; A Jacobs; R Mielke; I Slansky; M Würker; W D Heiss
Journal:  J Nucl Med       Date:  1994-12       Impact factor: 10.057

6.  Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs.

Authors:  S L Dabora; S Jozwiak; D N Franz; P S Roberts; A Nieto; J Chung; Y S Choy; M P Reeve; E Thiele; J C Egelhoff; J Kasprzyk-Obara; D Domanska-Pakiela; D J Kwiatkowski
Journal:  Am J Hum Genet       Date:  2000-12-08       Impact factor: 11.025

7.  Epilepsy surgery in young children with tuberous sclerosis: results of a novel approach.

Authors:  Howard L Weiner; Chad Carlson; Emily B Ridgway; Charles M Zaroff; Daniel Miles; Josiane LaJoie; Orrin Devinsky
Journal:  Pediatrics       Date:  2006-05       Impact factor: 7.124

Review 8.  Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria.

Authors:  E S Roach; M R Gomez; H Northrup
Journal:  J Child Neurol       Date:  1998-12       Impact factor: 1.987

9.  Uptake and release of tryptophan and serotonin: an HPLC method to study the flux of endogenous 5-hydroxyindoles through synaptosomes.

Authors:  W A Wolf; D M Kuhn
Journal:  J Neurochem       Date:  1986-01       Impact factor: 5.372

10.  The natural history of epilepsy in tuberous sclerosis complex.

Authors:  Catherine J Chu-Shore; Philippe Major; Susana Camposano; David Muzykewicz; Elizabeth A Thiele
Journal:  Epilepsia       Date:  2009-12-22       Impact factor: 5.864

View more
  19 in total

Review 1.  Neuroimaging of epilepsy.

Authors:  Fernando Cendes; William H Theodore; Benjamin H Brinkmann; Vlastimil Sulc; Gregory D Cascino
Journal:  Handb Clin Neurol       Date:  2016

Review 2.  Pediatric epilepsy surgery.

Authors:  Anuj Jayakar; Jeffrey Bolton
Journal:  Curr Neurol Neurosci Rep       Date:  2015-06       Impact factor: 5.081

3.  [Chinese expert consensus on surgical treatment of tuberous sclerosis complex-related epilepsy].

Authors: 
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2019-08

Review 4.  Dysplasia and overgrowth: magnetic resonance imaging of pediatric brain abnormalities secondary to alterations in the mechanistic target of rapamycin pathway.

Authors:  Shai Shrot; Misun Hwang; Carl E Stafstrom; Thierry A G M Huisman; Bruno P Soares
Journal:  Neuroradiology       Date:  2017-12-26       Impact factor: 2.804

Review 5.  Brain imaging in the assessment for epilepsy surgery.

Authors:  John S Duncan; Gavin P Winston; Matthias J Koepp; Sebastien Ourselin
Journal:  Lancet Neurol       Date:  2016-02-24       Impact factor: 44.182

Review 6.  Utility of MRI, PET, and ictal SPECT in presurgical evaluation of non-lesional pediatric epilepsy.

Authors:  Csaba Juhász; Flóra John
Journal:  Seizure       Date:  2019-05-11       Impact factor: 3.184

7.  Cortical Tubers: Windows into Dysregulation of Epilepsy Risk and Synaptic Signaling Genes by MicroRNAs.

Authors:  Alan A Dombkowski; Carlos E Batista; Daniela Cukovic; Nicholas J Carruthers; Ramya Ranganathan; Upasana Shukla; Paul M Stemmer; Harry T Chugani; Diane C Chugani
Journal:  Cereb Cortex       Date:  2014-12-01       Impact factor: 5.357

Review 8.  Biomarkers of epileptogenesis: psychiatric comorbidities (?).

Authors:  Andres M Kanner; Andrey Mazarati; Matthias Koepp
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

9.  Surgical treatment for refractory epileptic spasms: The Detroit series.

Authors:  Harry T Chugani; Mohammed Ilyas; Ajay Kumar; Csaba Juhász; William J Kupsky; Sandeep Sood; Eishi Asano
Journal:  Epilepsia       Date:  2015-11-02       Impact factor: 5.864

Review 10.  Comparison of amino acid positron emission tomographic radiotracers for molecular imaging of primary and metastatic brain tumors.

Authors:  Csaba Juhász; Shalini Dwivedi; David O Kamson; Sharon K Michelhaugh; Sandeep Mittal
Journal:  Mol Imaging       Date:  2014       Impact factor: 4.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.